Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrarosa for postmenopausal vulvovaginal atrophy in Chinese women
CTR20211153Phase 3Completed
- Sponsor
- Endoceutics
- Start
- May 2021
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dehydroepiandrosterone in vaginal atrophy, sponsored by Endoceutics. Started May 2021; status: completed.
02
Drugs
dehydroepiandrosterone
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on CTR20211153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211153.